Vol. 26 No. 3 (2022)
Endovascular Surgery

Permanent pacemaker implantation after transcatheter self-expanding aortic valve replacement: data from a single-center registry

PDF (Русский)
  • A.A. Baranov,
  • O.V. Krestyaninov,
  • D.A. Khelimskii,
  • A.G. Badoyan,
  • R.U. Ibragimov,
  • A.P. Gorgulko,
  • S.N. Manukyan,
  • Sh.Sh. Zajnobidinov
A.A. Baranov
Meshalkin National Medical Research Center
Bio
O.V. Krestyaninov
Meshalkin National Medical Research Center
D.A. Khelimskii
Meshalkin National Medical Research Center
A.G. Badoyan
Meshalkin National Medical Research Center
R.U. Ibragimov
Meshalkin National Medical Research Center
A.P. Gorgulko
Meshalkin National Medical Research Center
S.N. Manukyan
Meshalkin National Medical Research Center
Sh.Sh. Zajnobidinov
Meshalkin National Medical Research Center
DOI: https://doi.org/10.21688/1681-3472-2022-3-50-63

Published 2022-09-30

Keywords

  • Aortic Valve Stenosis,
  • Bundle-Branch Block,
  • Pacemaker, Artificial,
  • Transcatheter Aortic Valve Replacement

How to Cite

Baranov, A., Krestyaninov, O., Khelimskii, D., Badoyan, A., Ibragimov, R., Gorgulko, A., Manukyan, S., & Zajnobidinov, S. (2022). Permanent pacemaker implantation after transcatheter self-expanding aortic valve replacement: data from a single-center registry. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 26(3), 50–63. https://doi.org/10.21688/1681-3472-2022-3-50-63

Copyright (c) 2022 Baranov A.A., Krestyaninov O.V., Khelimskii D.A., Badoian A.G., Ibragimov R.U., Gorgulko A.P., Manukian S.N., Zaynobidinov Sh.Sh.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Background. Transcatheter aortic valve replacement is a safe and effective procedure in patients with severe aortic stenosis who are at high surgical risk. One of the most commonly diagnosed complications after transcatheter aortic valve replacement is postoperative complete heart block, requiring in most cases the permanent pacemaker implantation.
Aim. The study aims to identify independent prognostic factors of permanent pacemaker implantation after transcatheter aortic valve replacement.
Methods. This retrospective study included 336 patients who underwent transcatheter self-expanding aortic valve replacement between 2015 and 2021. 28 patients (8.3%) after procedure required the permanent pacemaker implantation. Patients with a previously implanted permanent pacemaker, surgical aortic valve replacement, transcatheter aortic valve replacement in history and patients after conversion of endovascular intervention to surgical replacement were excluded from the study.
Results. The mean age of patients was 75.4 ± 7.4 years. Diabetes mellitus (50.0 versus 28.6%, p = 0.03), baseline right bundle-branch block (32.1 versus 3.9%, p < 0.05), and smaller length of the interventricular membranous septum (5.5 ± 2.2 and 6.9 ± 1.8 mm, p < 0.05) were more common in the permanent pacemaker implantation patient group. The groups were comparable in terms of other clinical, demographic and instrumental characteristics. There were no statistically significant differences between the groups in major procedural complications. Independent prognostic factors of permanent pacemaker implantation were baseline complete right bundle-branch block (OR 21.01, 95% CI 5.86–75.42, p < 0,001), mean transcatheter aortic valve implantation depth below the aortic annulus (OR 1.42, 95% CI 1.16–1.74, p = 0.001) and the length of the interventricular membranous septum (OR 0.7, 95% CI 0.50–0.95, p = 0.02).
Conclusion. The frequency permanent pacemaker implantation after transcatheter aortic valve replacement procedure depends on some initial clinical factors, procedural aspects, and postoperative conduction disorders. In this registry, independent prognostic factors of a permanent pacemaker implantation were the baseline complete right bundle-branch block, mean transcatheter aortic valve implantationdepth and the length of the interventricular membranous septum.

Received 19 March 2022. Revised 18 April 2022. Accepted 19 April 2022.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

Contribution of the authors
Conception and study design: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh. Zaynobidinov
Data collection and analysis: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian
Statistical analysis: A.A. Baranov, A.G. Badoian, D.A. Khelimskii
Drafting the article: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh. Zaynobidinov
Critical revision of the article: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh. Zaynobidinov
Final approval of the version to be published: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh. Zaynobidinov

PDF (Русский)

References

  1. Сердечно-сосудистая хирургия: руководство / под ред. В.И. Бураковского, Л.А. Бокерии. 2-е изд., доп. М.: Медицина, 1996. 768 с. Burakovsky V.I., Bockeria L.A., editors. A guide to cardiovascular surgery. 2nd ed. Moscow: Meditsina Publ.; 1996. 768 p. (In Russ.)
  2. Akodad M., Schurtz G., Adda J., Leclercq F., Roubille F. Management of valvulopathies with acute severe heart failure and cardiogenic shock. Arch Cardiovasc Dis. 2019;112(12):773-780. PMID: 31492536. https://doi.org/10.1016/j.acvd.2019.06.009
  3. Имаев Т.Э., Комлев А.Е., Лепилин П.М., Колегаев А.С., Саличкин Д.В., Кучин И.В., Акчурин Р.С. Первый опыт транскатетерной имплантации самораскрывающегося биопротеза нового поколения Acurate neo. Российский ­кардиологический журнал. 2019;(8):59-64. https://doi.org/10.15829/1560-4071-2019-8-59-64 Imaev T.E., Komlev A.E., Lepilin P.M., Kolegaev A.S., Salichkin D.V., Kuchin I.V., Akchurin R.S. First experience of transcatheter implantation of new-generation self-expanding bioprosthesis Acurate neo. Russian Journal of Cardiology. 2019;(8):59-64. (In Russ.) https://doi.org/10.15829/1560-4071-2019-8-59-64
  4. Arora S., Vavalle J.P. Transcatheter aortic valve replacement in intermediate and low risk patients — clinical evidence. Ann Cardiothorac Surg. 2017;6(5):493-497. PMID: 29062744; PMCID: PMC5639231. https://doi.org/10.21037/acs.2017.07.01
  5. Mack M.J., Leon M.B., Thourani V.H., Makkar R., Kodali S.K., Russo M., Kapadia S.R., Malaisrie S.C., Cohen D.J., Pibarot P., Leipsic J., Hahn R.T., Blanke P., Williams M.R., McCabe J.M., Brown D.L., Babaliaros V., Goldman S., Szeto W.Y., Genereux P., Pershad A., Pocock S.J., Alu M.C., Webb J.G., Smith C.R., PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705. PMID: 30883058. https://doi.org/10.1056/NEJMoa1814052
  6. Popma J.J., Deeb G.M., Yakubov S.J., Mumtaz M., Gada H., O’Hair D., Bajwa T., Heiser J.C., Merhi W., Kleiman N.S., Askew J., Sorajja P., Rovin J., Chetcuti S.J., Adams D.H., Teirstein P.S., Zorn 3rd G.L., Forrest J.K., Tchétché D., Resar J., Walton A., Piazza N., Ramlawi B., Robinson N., Petrossian G., Gleason T.G., Oh J.K., Boulware M.J., Qiao H., Mugglin A.S., Reardon M.J., Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706-1715. PMID: 30883053. https://doi.org/10.1056/NEJMoa1816885
  7. Chamandi C., Barbanti M., Munoz-Garcia A., Latib A., Nombela-Franco L., Gutiérrez-Ibanez E., Veiga-Fernandez G., Cheema A.N., Cruz-Gonzalez I., Serra V., Tamburino C., Mangieri A., Colombo A., Jiménez-Quevedo P., Elizaga J., Lee D.-H., Garcia Del Blanco B., Puri R., Côté M., Philippon F., Rodés-Cabau J. Long-term outcomes in patients with new-onset persistent left bundle branch block following TAVR. JACC Cardiovasc Interv. 2019;12(12):1175-1184. PMID: 31129090. https://doi.org/10.1016/j.jcin.2019.03.025
  8. Nazif T.M., Dizon J.M., Hahn R.T., Xu K., Babaliaros V., Douglas P.S., El-Chami M.F., Herrmann H.C., Mack M., Makkar R.R., Miller D.C., Pichard A., Tuzcu E.M., Szeto W.Y., Webb J.G., Moses J.W., Smith C.R., Williams M.R., Leon M.B., Kodali S.K. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv. 2015;8(1 Pt A):60-69. PMID: 25616819. https://doi.org/10.1016/j.jcin.2014.07.022
  9. Haunschild J., Misfeld M., Schroeter T., Lindemann F., Davierwala P., von Aspern K., Spampinato R.A., Weiss S., Borger M.A., Etz C.D. Prevalence of permanent pacemaker implantation after conventional aortic valve replacement — a propensity-matched analysis in patients with a bicuspid or tricuspid aortic valve: a benchmark for transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2020;58(1):130-137. PMID: 32211779. https://doi.org/10.1093/ejcts/ezaa053
  10. Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J., Capodanno D., Conradi L., De Bonis M., De Paulis R., Delgado V., Freemantle N., Gilard M., Haugaa K.H., Jeppsson A., Jüni P., Pierard L., Prendergast B.D., Sádaba J.R., Tribouilloy C., Wojakowski W., ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. PMID: 34453165. https://doi.org/10.1093/eurheartj/ehab395
  11. Sievers H.-H., Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133(5):1226-1233. PMID: 17467434. https://doi.org/10.1016/j.jtcvs.2007.01.039
  12. Jilaihawi H., Zhao Z., Du R., Staniloae C., Saric M., Neuburger P.J., Querijero M., Vainrib A., Hisamoto K., Ibrahim H., Collins T., Clark E., Pushkar I., Bamira D., Benenstein R., Tariq A., Williams M. Minimizing permanent pacemaker following repositionable self-expanding transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12(18):1796-1807. PMID: 31473236. https://doi.org/10.1016/j.jcin.2019.05.056
  13. Shahian D.M., O’Brien S.M., Filardo G., Ferraris V.A., Haan C.K., Rich J.B., Normand S.-L.T., DeLong E.R., Shewan C.M., Dokholyan R.S., Peterson E.D., Edwards F.H., Anderson R.P. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1 — coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2-S22. PMID: 19559822. https://doi.org/10.1016/j.athoracsur.2009.05.053
  14. Rogers T., Thourani V.H., Waksman R. Transcatheter aortic valve replacement in intermediate- and low-risk patients. J Am Heart Assoc. 2018;7(10):e007147. PMID: 29754127; PMCID: PMC6015326. https://doi.org/10.1161/JAHA.117.007147
  15. Ревишвили А.Ш., Артюхина Е.А., Глезер М.Г., Базаев В.А., Баталов Р.Е., Бокерия Л.А., Бокерия О.Л., Давтян К.В., Иваницкий Э.А., Ковалев А.С., Криволапов С.Н., Лебедев Д.С., Лебедева В.К., Любимцева Т.А., Мамчур С.Е., Михайлов Е.Н., Неминущий Н.М., Попов С.В., Рзаев Ф.Г., Романов А.Б., Сергуладзе С.Ю., Сопов О.В., Филатов А.Г. Брадиаритмии и нарушения проводимости. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(4):4448. https://doi.org/10.15829/1560-4071-2021-4448 Revishvili A.Sh., Artyukhina E.A., Glezer M.G., Bazaev V.A., Batalov R.E., Bokeria L.A., Bokeria O.L., Davtyan K.V., Ivanitsky E.A., Kovalev A.S., Krivolapov S.N., Lebedev D.S., Lebedeva V.K., Lyubimtseva T.A., Mamchur S.E., Mikhailov E.N., Neminushchy N.M., Popov S.V., Rzaev F.G., Romanov A.B., Serguladze S.Yu., Sopov O.V., Filatov A.G. 2020 Clinical practice guidelines for Bradyarrhythmias and conduction disorders. Russian Journal of Cardiology. 2021;26(4):4448. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4448
  16. Chen S., Chau K.H., Nazif T.M. The incidence and impact of cardiac conduction disturbances after transcatheter aortic valve replacement. Ann Cardiothorac Surg. 2020;9(6):452-467. PMID: 33312903; PMCID: PMC7724062. https://doi.org/10.21037/acs-2020-av-23
  17. Du F., Zhu Q., Jiang J., Chen H., Liu X., Wang J. Incidence and predictors of permanent pacemaker implantation in patients who underwent transcatheter aortic valve replacement: observation of a chinese population. Cardiology. 2020;145(1):27-34. PMID: 31722361. https://doi.org/10.1159/000502792
  18. Auffret V., Puri R., Urena M., Chamandi C., Rodriguez-Gabella T., Philippon F., Rodés-Cabau J. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017;136(11):1049-1069. PMID: 28893961. https://doi.org/10.1161/CIRCULATIONAHA.117.028352
  19. Urena M., Mok M., Serra V., Dumont E., Nombela-Franco L., DeLarochellière R., Doyle D., Igual A., Larose E., Amat-Santos I., Côté M., Cuéllar H., Pibarot P., de Jaegere P., Philippon F., Garcia del Blanco B., Rodés-Cabau J. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol. 2012;60(18):1743-1752. PMID: 23040577. https://doi.org/10.1016/j.jacc.2012.07.035
  20. Roten L., Meier B. Left bundle branch block after transcatheter aortic valve implantation: still a matter of concern? JACC Cardiovasc Interv. 2014;7(2):137-139. PMID: 24440019. https://doi.org/10.1016/j.jcin.2013.11.006
  21. Kawashima T., Sato F. Visualizing anatomical evidences on atrioventricular conduction system for TAVI. Int J Cardiol. 2014;174(1):1-6. PMID: 24750717. https://doi.org/10.1016/j.ijcard.2014.04.003
  22. Regueiro A., Altisent O.A.-J., Del Trigo M., Campelo-Parada F., Puri R., Urena M., Philippon F., Rodés-Cabau J. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9(5):e003635. PMID: 27169577. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003635
  23. Siontis G.C.M., Juni P., Pilgrim T., Stortecky S., Büllesfeld L., Meier B., Wenaweser P., Windecker S. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129-140. PMID: 25011716. https://doi.org/10.1016/j.jacc.2014.04.033
  24. Waksman R., Steinvil A. Pre-transcatheter aortic valve replacement right bundle branch block: a bundle of trouble. JACC Cardiovasc Interv. 2017;10(15):1575-1577. PMID: 28734886. https://doi.org/10.1016/j.jcin.2017.06.012
  25. Fadahunsi O.O., Olowoyeye A., Ukaigwe A., Li Z., Vora A.N., Vemulapalli S., Elgin E., Donato A. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2016;9(21):2189-2199. PMID: 27832844. https://doi.org/10.1016/j.jcin.2016.07.026
  26. Roten L., Stortecky S., Scarcia F., Kadner A., Tanner H., Delacrétaz E., Meier B., Windecker S., Carrel T., Wenaweser P. Atrioventricular conduction after transcatheter aortic valve implantation and surgical aortic valve replacement. J Cardiovasc Electrophysiol. 2012;23(10):1115-1122. PMID: 22587564. https://doi.org/10.1111/j.1540-8167.2012.02354.x
  27. Kusumoto F.M., Schoenfeld M.H., Barrett C., Ed­gerton J.R., Ellenbogen K.A., Gold M.R., Gold­schlager N.F., Hamilton R.M., Joglar J.A., Kim R.J., Lee R., Marine J.E., McLeod C.J., Oken K.R., Patton K.K., Pellegrini C.N., Selzman K.A., Thompson A., Varosy P.D. 2018 ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(7):932-987. PMID: 30412710. https://doi.org/10.1016/j.jacc.2018.10.043
  28. Mangieri A., Montalto C., Pagnesi M., Lanzillo G., Demir O., Testa L., Colombo A., Latib A. TAVI and post procedural cardiac conduction abnormalities. Front Cardiovasc Med. 2018;5:85. PMID: 30018969; PMCID: PMC6038729. https://doi.org/10.3389/fcvm.2018.00085
  29. Erkapic D., De Rosa S., Kelava A., Lehmann R., Fichtlscherer S., Hohnloser S.H. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23(4):391-397. PMID: 22050112. https://doi.org/10.1111/j.1540-8167.2011.02211.x
  30. Watanabe Y., Kozuma K., Hioki H., Kawashima H., Nara Y., Kataoka A., Nagura F., Nakashima M., Shirai S., Tada N., Araki M., Takagi K., Yamanaka F., Yamamoto M., Hayashida K. Pre-existing right bundle branch block increases risk for death after transcatheter aortic valve replacement with a balloon-expandable valve. JACC Cardiovasc Interv. 2016;9(21):2210-2216. PMID: 27832846. https://doi.org/10.1016/j.jcin.2016.08.035
  31. Auffret V., Webb J.G., Eltchaninoff H., Muñoz-García A.J., Himbert D., Tamburino C., Nombela-Franco L., Nietlispach F., Morís C., Ruel M., Dager A.E., Serra V., Cheema A.N., Amat-Santos I.J., de Brito F.S. Jr, Lemos P.A., Abizaid A., Sarmento-Leite R., Dumont E., Barbanti M., Durand E., Alonso Briales J.H., Vahanian A., Bouleti C., Immè S., Maisano F., Del Valle R., Benitez L.M., García Del Blanco B., Puri R., Philippon F., Urena M., Rodés-Cabau J. Clinical impact of baseline right bundle branch block in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10(15):1564-1574. PMID: 28734885. https://doi.org/10.1016/j.jcin.2017.05.030
  32. Hamdan A., Guetta V., Klempfner R., Konen E., Raanani E., Glikson M., Goitein O., Segev A., Barbash I., Fefer P., Spiegelstein D., Goldenberg I., Schwammenthal E. Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2015;8(9):1218-1228. PMID: 26292585. https://doi.org/10.1016/j.jcin.2015.05.010
  33. Maeno Y., Abramowitz Y., Kawamori H., Kazuno Y., Kubo S., Takahashi N., Mangat G., Okuyama K., Kashif M., Chakravarty T., Nakamura M., Cheng W., Friedman J., Berman D., Makkar R.R., Jilaihawi H. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1139-1147. PMID: 28412434. https://doi.org/10.1016/j.jcmg.2016.11.020
  34. Piazza N., Nuis R.-J., Tzikas A., Otten A., Onuma Y., García-García H., Schultz C., van Domburg R., van Es G.-A., van Geuns R., de Jaegere P., Serruys P.W. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention. 2010;6(4):475-484. PMID: 20884435. https://doi.org/10.4244/EIJ30V6I4A80
  35. van Gils L., Wohrle J., Hildick-Smith D., Bleiziffer S., Blackman D.J., Abdel-Wahab M., Gerckens U., Brecker S., Bapat V., Modine T., Soliman O.I., Nersesov A., Allocco D., Falk V., Van Mieghem N.M. Importance of contrast aortography with lotus transcatheter aortic valve replacement: a post hoc analysis from the RESPOND post-market study. JACC Cardiovasc Interv. 2018;11(2):119-128. PMID: 29348006. https://doi.org/10.1016/j.jcin.2017.10.016